Dianthus Therapeutics, Inc. (DNTH) income statement
DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$83.98−3.00 (-3.45%)
Close on Nov 18, 2026Market cap $4.70BP/E –Yield 0.00%
Dianthus Therapeutics, Inc. financial ratios
See a number that looks wrong?